Abstract
Hepatitis C virus infection is being considered a challenge for the health system due to the chronic carriers who became infected while receiving blood transfusion before the establishment of serological screening in blood banks or through other forms of parenteral transmission. Treatment of this infection has been established and refined since the late 90s of last century. The treatment …